期刊文献+

急性粒-单核细胞白血病的细胞遗传学异常研究 被引量:3

The study of the cytogenetic abnormalities in acute myelomonocytic leukemia
下载PDF
导出
摘要 背景与目的2001年WHO分型特别提出4种伴再现性遗传学异常的急性髓细胞白血病(AML),其中inv(16)(p13;q22)与急性粒-单核细胞白血病(M4)密切相关,是预后好的标志。本研究旨在探讨M4的细胞遗传学特征。方法采用直接法及短期培养法制备骨髓细胞染色体,并以R显带技术对89例M4患者进行核型分析,并应用间期荧光原位杂交(I-FISH)技术对其中伴有+22异常的患者进行inv(16)检测。结果89例M4患者中,异常染色体检出率为40.4%(36/89),共12种主要异常核型,其中5种为特异性染色体异常,见于25例患者,占核型异常患者的69.4%。单纯+8(10例)为最常见的数目异常;结构异常最多见的是inv(16)(5例);t(8;21)者3例;伴t(9;22)者有1例;其中5例inv(16)及3例+22均只见于M4Eo患者。3例+22患者FISH检测inv(16)均阳性。结论细胞遗传学研究对于急性粒-单核细胞白血病的诊断具有重要价值,但是细胞遗传学对inv(16)检测阳性低,对怀疑病例及所有+22异常的患者,应尽可能进行FISH检测。 Background and purpose: Four subtypes of acute myeloid leukemia (AML) with recurrent cytogenetic abnormalities were classified using criteria of the World Health Organization (WHO) of Tumors in 2001, inv(16) (p13q22) has been found to be one of the good prognostic factors and is closely associated with acute myelomonocytic leukemia ( M4). The objective of this study was to investigate the cytogenetic abnormalities of acute myelomonocytic leukemia ( M4). Methods: Chromosome of bone marrow was prepared by both direct and short-term culture. Karyotyping analysis was performed on 89 patients with M4 with R-banding technique. Fluorescence in situ hybridization (FISH) was used to detect inv(16) for the patients with trisomy 22. Results: Thirty-six cases (40.4%) had clone chromosomal abnormalities and 12 categories of major abnormalities were found, five specific abnormalities of 12 were. seen in 25 cases, accounting for 69.4% of all patients with karyotypic abnormalities. Isolate trisomy 8( 10 cases) was the most common abnormality and inv(16) (5 cases) was the most frequent structural abnormality. Three cases had t( 8; 21) and one had t(9; 22). Five inv(16) and three trisomy 22 were detected only in the patients with M4Eo. inv(16) was positive in all three cases with trisomy 22 FISH analysis. Conclusions: Cytogenetic analysis was important for the diagnosis of M4. but inv(16) was difficult to be detected by cytogenetic analysis, for the patients either suspected or with trisomy 22, FISH analysis was strongly recommended for the detection of inv(16).
出处 《中国癌症杂志》 CAS CSCD 2006年第9期733-736,共4页 China Oncology
基金 江苏省135工程医学重点人才基金资助(RC2002044)。
关键词 急性粒-单核细胞白血病 细胞遗传学 核型分析 荧光原位杂交 acute myelomonocytic leukemia cytogenetics karyotyping fluorescence in situ hybridization
  • 相关文献

参考文献7

二级参考文献19

  • 1Grimwde D, Walker H, Harrison C,et al. Impact of diagnostic cytogenetics on outcome in AML analysis of 1 613 patients entered into the UK MRC AML 10 trial[J]. Blood, 1996,88:2525a.
  • 2Liu P P, Hajra A, Wijmenga C, et al. Molecular pathogenesis of the chromosome 16 inversion in the M4E0 subtype of acute myeloid leukemia[J]. Blood, 1995,85(9):2289--2302.
  • 3Poirel H, Radford-Weiss I, Rack K, et al. Detection of the chromosome 16 CBFβ-MYH11 fusion transcripts in myelomonocytic leukemias[J]. Blood, 1995,85:1313--1322.
  • 4Shurtleff S A, Meyers S, Hiebert S W, et al. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t ( 16, 16) (p13, q22 ) in acute myelogenous leukemia[J]. Blood , 1995,85:3695--3703.
  • 5Grois N, Nowotony H, Tyl E, et al. Is trisomy 22 in acute myeloid leukemia a primary abnormality or only a secondary change associated with inversion 16[J]. Cancer Genet Cytogenet, 1989,43:119.
  • 6Litmanovich D, Zamir-Brill R, Jeison M, et al. Is inversion 16 a prerequisite and is trisomy 22 invariably associated with inversion 16 in AML-M4Eo[J]. Cancer Gent Cytogenet, 2000,121 : 106.
  • 7Mitterbauer M, Laczika K. High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study[J].Am J Clin Pathol, 2000,113(3):406--410.
  • 8Mancini M, Cedrone M, Diverio D, et al. Use of dual-color interphase FISH for the detection of inv(16) in AML at diagnosis, relapse and during follow-up: a study of 23 patients [J].Leukemia, 2000 ,14(3) :364--368.
  • 9Langabeer S E, Grimwade D, Walker H, et al. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARa, AML1/ETO and CBFB/MYHll respectively in acute myeloid leukemia[J]. Br J Haematol, 1998,101:338--340.
  • 10Wong K F, Kwong Y L. Trisomy 22 in acute myeloid leukemia: a marker for myeloid leukemia with monocytic features and cytogenetically cryptic inversion 16[J]. Cancer Genet Cytogenet,1999,109:131-- 133.

共引文献25

同被引文献26

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部